ST
ALXN

Sageworth Trust’s Alexion Pharmaceuticals ALXN Stock Holding History

Sageworth Trust’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-115
Closed -$21K – 902
2021
Q2 		$21K Hold
115
– – ﹤0.01% 391
2021
Q1 		$18K Hold
115
– – ﹤0.01% 236
2020
Q4 		$18K Hold
115
– – ﹤0.01% 167
2020
Q3 		$13K Hold
115
– – ﹤0.01% 136
2020
Q2 		$13K Hold
115
– – ﹤0.01% 124
2020
Q1 		$10K Hold
115
– – ﹤0.01% 126
2019
Q4 		$12K Buy
+115
New +$12.3K ﹤0.01% 149

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $13.1B AUM 28.37% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $434M AUM 44.19% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $1.1B AUM 26.6% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Sageworth Trust's ALXN Position: Q3 2021 in Review

Sageworth Trust sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 115 shares — an estimated $21K sold.

Sageworth Trust first reported a position in ALXN in Q4 2019 and held it in 7 quarters. The position peaked at $21K in Q2 2021. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • Sageworth Trust reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Sageworth Trust sold 115 Alexion Pharmaceuticals shares in Q3 2021, an estimated $21K.
  • Sageworth Trust first reported a position in Alexion Pharmaceuticals in Q4 2019 and held it in 7 quarters.
  • Sageworth Trust's Alexion Pharmaceuticals position peaked at $21K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on Sageworth Trust's 13F filing for Q3 2021, filed 9 Nov 2021.